J
Jianjiang Xu
Researcher at Fudan University
Publications - 154
Citations - 3578
Jianjiang Xu is an academic researcher from Fudan University. The author has contributed to research in topics: Cornea & Glaucoma. The author has an hindex of 26, co-authored 142 publications receiving 2575 citations. Previous affiliations of Jianjiang Xu include Fudan University Shanghai Medical College & China Academy of Engineering Physics.
Papers
More filters
Journal ArticleDOI
TFOS DEWS II Management and Therapy Report
Lyndon Jones,Laura E Downie,Donald R. Korb,Jose M. Benitez-del-Castillo,Reza Dana,Sophie X. Deng,Pham N. Dong,Gerd Geerling,Richard Y Hida,Yang Liu,Kyoung Yul Seo,Joseph Tauber,Tais Hitomi Wakamatsu,Jianjiang Xu,James S. Wolffsohn,Jennifer P. Craig +15 more
TL;DR: It became clear that many of the treatments available for the management of dry eye disease lack the necessary Level 1 evidence to support their recommendation, often due to a lack of appropriate masking, randomization or controls and in some cases due to issues with selection bias or inadequate sample size.
Journal ArticleDOI
A new tonometer--the Corvis ST tonometer: clinical comparison with noncontact and Goldmann applanation tonometers.
TL;DR: The CST offers an alternative method for measuring intraocular pressure (IOP) measurements obtained using the Topocon noncontact tonometer, the Goldmann applanation tonometer (GAT), and the Corvis ST, a newly developed tonometer with features of visualization and measurement of the corneal deformation response to an air impulse.
Journal ArticleDOI
Assessment of tear film stability in dry eye with a newly developed keratograph.
TL;DR: Measurements of NI-BUT obtained with the newly developed corneal topographer may provide a simple, noninvasive screening test for dry eyes with acceptable sensitivity, specificity, and repeatability.
Journal ArticleDOI
The diagnosis of limbal stem cell deficiency
TL;DR: With the application of newly developed ocular imaging modalities and molecular methods as diagnostic tools, standardized quantitative criteria for the staging of L SCD can be established and effective patient-specific therapy for different stages of LSCD may be feasible.
Journal ArticleDOI
Impact of Dry Eye Syndrome on Vision-Related Quality of Life in a Non-Clinic-Based General Population
TL;DR: The symptoms of dry eye are associated with an adverse impact on vision-related QoL in non-clinic-based general population, which is mainly represented as more ocular pain and discomfort, and impaired mental health as well.